Introduction
Polyomavirus (Py), a member of the papovaviruses, causes tumors in rodents, immortalizes primary cells and transforms established cells in culture. The proteins mediating these activities are encoded by the early Py transcription unit. The early region produces dierentially spliced mRNAs (Soeda et al., 1980) that encode small, middle and large T-antigen (LT-Ag), as well as the recently described tiny T-Ag (Riley et al., 1997) . When expressed in primary cultures, PyLT-Ag confers an unlimited growth potential to cells and is responsible for the decreased serum requirement of Py transformed cells (Rassoulzadegan et al., 1982 (Rassoulzadegan et al., , 1983 . In addition, PyLT-Ag can cooperate with other oncogenes to confer a complete transformed phenotype (Rassoulzadegan et al., 1982) . PyLT-Ag binds to the Rb gene product in vivo through its CR2 domain (Khandjian and Tremblay, 1992; Resnick-Silverman et al., 1991) . Mutants that fail to bind Rb are inactive in immortalization assays (Larose et al., 1990 (Larose et al., , 1991 Pilon et al., 1996) . The amino-terminal CR1 domain contains a DNA J homology domain which can stimulate Hsp70 (ATPase activity (Brodsky and Pipas, 1998; Kelley and Georgopoulos, 1997; Sheng et al., 1997) . While some observations have suggested a role of PyLT-Ag in modulating apoptosis, its exact role remains as yet unknown (Fimia et al., 1998; Gottifredi et al., 1999; Lebel et al., 1996; Zheng et al., 1994) .
Apoptosis or programmed cell death, is a conserved mechanism essential during embryogenesis and development, and maintains tissue homeostasis of the adult (Vaux and Korsmeyer, 1999) . It is implicated in many diseases including cancer, auto-immune and neurodegenerative disorders (Mountz et al., 1997; Thompson, 1995) . Apoptosis is critical for cellular mediated immune response since cytolytic and natural killer T cells induce apoptosis via granzyme B release, TNF-a or FasL exposure (Chinnaiyan and Dixit, 1997; Rathmell and Thompson, 1999; Siegel and Fleisher, 1999) . The receptors of FasL, CD95/Apo1/FasR, and TNF-a, TNF-R1, are part of a growing family called the cell death receptor family. Upon binding of their respective ligands, the oligomerization of the cell death receptors induces the formation of death-inducing signaling complexes (DISC). These DISC transmit the external apoptotic signals to the cytoplasm, mitochondria, and ultimately to the nuclei, leading to the characteristic DNA degradation associated with apoptosis. The FasR and TNF-R1 signal transduction cascades have been extensively studied and reviewed recently (Baker and Reddy, 1998; Kidd, 1998; Nagata, 1997; Schmitt et al., 1999; Wallach et al., 1999) .
As part of their lytic cycle, viruses have developed strategies and appropriate viral gene products to either induce, delay, or totally block apoptosis (reviewed in Teodoro and Branton, 1997; Young et al., 1997) . As an example, the Cowpox virus CrmA protein can modify the host in¯ammatory response by inhibiting Ice/ caspase-1 (Ray et al., 1992; Yuan et al., 1993) . Caspase-1 inhibition reduces interleukin-1b production allowing the infected cell to evade the immune system. CrmA can also block apoptosis mediated by the activation of cell death receptors by inhibiting Mch5/ Flice/Mach/caspase-8, the ®rst caspase of the cascade recruited and activated following FasR and TNF-R1 stimulation (Boldin et al., 1996; Fernandes-Alnemri et al., 1996; Muzio et al., 1996; Tewari et al., 1995; Zhou et al., 1997) . The adenovirus E1B 19-kDa protein also indirectly inhibits caspase-8 by binding to Flash, a protein associated with the FasR DISC (Imai et al., 1999) . E1B 19-kDa is also thought to protect from apoptosis by acting as a functional homolog of Bcl-2, a cellular inhibitor of apoptosis (Boyd et al., 1994; Chen et al., 1996; Chiou et al., 1994; Han et al., 1998) .
PyLT-Ag and the related SV40LT-Ag are multifunctional proteins that have been shown to modulate some instances of apoptosis. SV40LT-Ag is sucient to protect CV-1 monkey cells against apoptosis induced by the over-expression of caspase-1 (Jung and . Independently, it was shown that full-length SV40LT-Ag can protect against apoptosis induced by an amino-terminal fragment of SV40LT-Ag (Conzen et al., 1997) . This anti-apoptotic function is p53-independent and localizes to a carboxy-terminal domain of the protein that contains a degenerate BH1 domain found in various Ced-9/Bcl-2 family members. While SV40LT-Ag appears to block apoptosis induced by growth factor withdrawal in a neural stem cell line (Slinskey et al., 1999) it has been reported that SV40 and PyLT-Ag cause apoptosis in dierentiating myoblasts (Endo and Nadal-Ginard, 1998; Fimia et al., 1998; Gottifredi et al., 1999) . Using temperaturesensitive mutants, both SV40LT-Ag and PyLT-Ag has been shown to protect cells from serum starvation-induced apoptosis (Zheng et al., 1994) . Other in vitro and vivo results also suggest that SV40LT-Ag is able to block FasR induced apoptosis (Gonin et al., 1999; Rouquet et al., 1995) , although the mechanism by which it does so is unclear. In addition, we have previously reported that the D-37-C1 Sertoli cell line derived from transgenic mice expressing PyLT-Ag are resistant to treatment with FasR agonist antibodies (FasR(Ab)) (Lebel et al., 1996) . These results have suggested that the inhibition of FasR(Ab)-induced apoptosis in these cells was attributable to PyLT-Ag expression. In this study, we investigated the eect of PyLT-Ag expression in two dierent murine cell lines sensitive to FasR(Ab) treatment, and observed that PyLT-Ag protected these cells from FasR(Ab)-induced apoptosis. Furthermore, the protective eect conferred by PyLT-Ag was not restricted to FasR(Ab) but also includes protection to TNF-a and taxol treatment.
Results

Expression of PyLT-Ag in TM4 and NSO murine cell lines
The TM4 Sertoli and the NSO hybridoma cell lines were transfected with the episomal PCEP4LT vector and stable populations were selected following hygromycinB selection. TM4 cells were also transfected with the PGKLT vector and G418 resistant clones were isolated (TM4-PGKLT1, 3 and 5). To assess the level of PyLT-Ag expression, mRNA and proteins were extracted from the parental cell lines and transfected clones or mixed populations. Level of PyLT-Ag expression was analysed by Northern ( Figure 1a ) and Western blot (Figure 1b) . Both TM4-PCEP4LT and NSO-PCEP4LT mixed populations expressed PyLTAg. The TM4-PGKLT clones expressed variable amounts of PyLT-Ag. By comparison with internal controls (b-actin in Figure 1a and Hsp 60 in Figure 1b ) there appears to be a good correlation between PyLTAg mRNA and protein pro®les in TM4-PGKLT1, 3 and 5 clones. In addition, there was no signi®cant change in procaspase-8 proteins level associated with PyLT-Ag expression. The TM4-PGKLT5 cell line, which showed strong PyLT-Ag expression, was used to test the eect of PyLT-Ag expression on apoptosis. Cells were treated with 150 U/ml of g-INF for 16 h to induce FasR expression and subsequently 1 mg/ml of FasR(Ab) was added at every 24 h interval (g-IFN/FasR(Ab)). Treatment with g-IFN for 16 h induced the expression of FasR in both TM4, TM4-PGKLT3 and TM4-PGKLT5 cells (Figure 1c) . A ®lter DNA elution assay was used to monitor and quantitate kinetics of DNA fragmentation in treated TM4 and TM4-PGKLT5 cells (Figure 2a DNA fragmentation reached about 40%, cells begun to round up, became refractile to light, and ®nally detached from the cell culture dish (Figure 2b ). These morphological changes are seen as early as 24 h in some TM4 cells. At 72 h for TM4 cells and 96 h for TM4-PGKLT5 cells, aberrant morphologies are evident and few normal adherent TM4 cells were observed at 96 h.
To assess if the protective activity was speci®c to TM4-PGKLT5 cells, we analysed the eect of g-IFN/ FasR(Ab) treatment in other TM4-PGKLT clones and in the TM4-PCEP4LT and NSO-PCEP4LT mixed cell populations. Decreased DNA fragmentation was observed in the TM4-PGKLT1 and three clones, and also in TM4-PCEP4LT cells (Figure 2c ). The lower levels of PyLT-Ag expression in these cells correlated with a more limited extent of protection following g-IFN/FasR(Ab) treatment. The NSO-PCEP4LT cells were also more resistant to g-IFN/FasR(Ab) treatment compared to the parental NSO cell line (Figure 2c ). Although both the parental NSO and NSO-PCEP4LT cells showed high background levels of DNA fragmentation, treatment increased the level of fragmented DNA up to 80% in NSO cells, while NSO-PCEP4LT cells maintained background levels of DNA fragmentation. These observations show that PyLT-Ag modulated FasR(Ab)-induced apoptosis in dierent cell types.
PyLT-Ag confers protection against TNF-a and taxol-induced apoptosis
We investigated whether PyLT-Ag can interfere with other apoptotic stimuli in TM4-PGKLT5 cells. First, TNF-a was tested since oligomerization of TNF-R1 by TNF-a binding induces a DISC formation that also recruits and activates caspase-8. Treatment of TM4-PGKLT5 cells with TNF-a for 48 h resulted in 35 ± 40% DNA fragmentation while the TM4 cells showed 75 ± 80% DNA fragmentation (Figure 3b ). These observations indicate that PyLT-Ag has only a partial protective eect against TNF-a-induced apoptosis. The response of TM4-PGKLT5 cells to taxol, a microtubule depolymerization inhibitor, and camptothecin, a DNA topoisomerase I inhibitor, was also examined.
Taxol treatment induced 40% DNA fragmentation in TM4 cells 48 h post-treatment, while camptothecin treatment triggered 80% DNA fragmentation ( Figure  3a,c) . The TM4-PGKLT5 cells were almost completely protected from taxol-induced DNA fragmentation, while no protection was observed in cells treated with camptothecin. (Figure 3a,c) . These results were con®rmed in two other PyLT-Ag expressing TM4 clones (data not shown). These observations reveal that PyLT-Ag interfered with taxol but not camtothecininduced apoptosis.
Sequential caspase activation is delayed in PyLT-Ag expressing cells stimulated by FasR(Ab) or taxol Activation of caspases are known to play a central role in apoptosis (Alnemri, 1997; Cryns and Yuan, 1998; Stennicke and Salvesen, 1998) . FasR stimulation by agonist antibodies leads to the formation of a DISC that recruits and activates procaspase-8. Once activated, caspase-8 promotes activation of procaspase-3 in a mitochondria-independent or -dependent manner Luo et al., 1998; Scadi et al., 1998) . Thus, we analysed the eect of PyLT-Ag expression on procaspase-8 and -3 activation in TM4, TM4-PGKLT3 and TM4-PGKLT5 cells after FasR(Ab) treatment. Caspase-8 and -3 activities were monitored from cellular extracts using as substrates, the¯uorescent derivative peptides z-IETD-AMC and z-DEVD-AFC, respectively. Note that the background activities of caspase-8 and -3 were similar in TM4 and TM4-PGKLT cells suggesting that PyLT-Ag expression does not aect the basal level of these caspases. FasR(Ab)-stimulated TM4 cells reached a peak of caspase-8 activity 2 h after stimulation and remained high for the next 4 h (Figure 4a ). Caspase-8 activity then diminished slowly until it reached the initial level of activity 12 h post-treatment. In treated TM4-PGKLT3 and 5 cells, caspase-8 was much less active and never attained the level seen in TM4 cells. These results clearly indicate that PyLT-Ag impedes the activation of procaspase-8 following FasR(Ab) stimulation. In TM4 cells, caspase-8 activation resulted in the rapid induction of caspase-3 activity beginning 6 h posttreatment (Figure 4b ). After reaching 106background, Figure 3 The eect of PyLT-Ag expression on DNA fragmentation induced by TNF-a, taxol and captothecin. Cells were treated for 48 h with 0.05, 0.2 or 0.5 mM taxol (a), 6700 U/ml TNF-a (b), or 10 mg/ml captothecin (c) prior to DNA fragmentation assays. Error bars represent the means+s.d. of three experiments. Symbols: open bars or circles, TM4; open squares, TM4-PGKLT3; closed bars or circles TM4-PGKLT5. Note that similar results were obtained with concentrations ranging from 1300 to 33 000 U/ml TNF-a, or from 1 ± 100 mg/ml captothecin the level of caspase-3 activity then increased slowly over time. In TM4-PGKLT3 and 5 cells, caspase-3 activation started slowly 12 ± 18 h post-treatment and eventually reached a high level of activation ( Figure  4b ). The slow activation of caspase-3 in the TM4-PGKLT3 and 5 cells after FasR(Ab) treatment, correlated with the slow activation of caspase-8 in these cells. Thus, lack of early caspase-3 activity seems to be a consequence of caspase-8 inactivation mediated by PyLT-Ag expression. Unlike FasR stimulation, procaspase-8 was not fully activated in control cells and only slightly delayed in the TM4-PGKLT5 clone in the presence of taxol, with no signi®cant dierence in the TM4-PGKLT3 cells (Figure 4c ). In contrast, caspase-3 activation was delayed in PyLT-Ag expressing TM4-PGKLT cells treated with taxol (Figure 4d ).
PyLT-Ag interacts with components of the DISC
To explain the lack of caspase-8 activation in FasR stimulated PyLT-Ag expressing cells, we investigated whether PyLT-Ag could interact with dierent components of the DISC. Since it is known that FasR stimulation induces the formation of the DISC we extracted proteins both before and after a 5 min stimulation of FasR in control and TM4-PGKLT5 cells. Following immunoprecipitations with anti-FADD or control anti-Hsp60 antibodies, proteins were electrophoresed, blotted and analysed for the presence of co-immunoprecipitated PyLT-Ag. No PyLT-Ag was observed in TM4 controls (Figure 5a, lanes 1 and 2) or immunoprecipitates using either pre-immune goat sera or anti-Hsp60 with TM4-PGKLT5 cells (Figure 5a , lanes 3 and 4). PyLT-Ag was observed, however, in TM4-PGKLT5 cell extracts immunoprecipitated with antibodies against FADD (Figure 5a, lane 5) . The intensity of PyLT-Ag staining was greatly enhanced following the stimulation of FasR (Figure 5a, lane 6) . Similar results with caspase-8 were dicult to visualize in the TM4-PGKLT5 cells (data not shown) and subsequent experiments were performed in NIH3T3 clones expressing varying amounts of PyLT-Ag. In particular, NIH-LT23 cells expressed similar amounts of PyLT-Ag as the TM4-PGKLT5 cells (data not shown) while NIH-LT7 cells expressed signi®cantly more PyLT-Ag (Figure 5b, compare lanes 14 and 15) . PyLT-Ag was observed in NIH-LT7 extracts following anti-caspase-8 and anti-FADD immunoprecipitations ( Figure 5b lanes 4 and 12) but not in the lower PyLTAg expressing NIH-LT23 cells (Figure 5b, lanes 3 and  11) . PyLT-Ag was not observed following immunoprecipitations with goat pre-immune serum or by an antiHsp60 antibody (data not shown).
Discussion
In this study we present evidence that PyLT-Ag protects cells from apoptosis induced by stimulation of cell death receptors and taxol treatment. The analysis of caspase activation after FasR(Ab) stimulation in the TM4 and TM4-PGKLT5 cells, suggests that the protective eect of PyLT-Ag occurs primarily at or upstream of caspase-8, preventing its recruitment or activation in the FasR DISC. This is based on the observations that in the TM4-PGKLT5 cells, caspase-8 activation is delayed and reduced as compared to the TM4 cells. For FasR, stimulation by the agonist antibodies leads to the formation of a DISC that contains FADD/MORT-1 and FLASH that recruits caspase-8 or -10 ( Baker and Reddy, 1998; Kidd, 1998; Nagata, 1997; Schmitt et al., 1999; Wallach et al., 1999) . E1B 19-kDa binds to FLASH and interferes with caspase-8 activation (Imai et al., 1999) . Our results suggest a similar function for PyLT-Ag in preventing caspase-8 activation in FasR(Ab)-treated cells. To determine whether PyLT-Ag interacts with the DISC, we used a co-immunoprecipitation approach to detect whether PyLT-Ag interacts either with FADD or caspase-8. Our results indicate that PyLT-Ag coimmunoprecipitates with FADD, and this interaction is strengthened following FAS receptor activation. This latter result suggests that PyLT-Ag might not directly interact with FADD/caspase-8 but rather with other components of the DISC, such as FLASH, which are recruited to the DISC complex following activation ( Figure 6 ). In our study, PyLT-Ag was less ecient in preventing TNF-a-induced apoptosis compared to FasR(Ab), although both receptors depend on caspase-8 activation to relay cell death signals within cells. However, for TNF-R1 the DISC contains the adapter molecule TRADD that recruits FADD and caspase-8, or alternatively TRADD recruits caspase-2 via a TRADD/RIP/CRADD/RAIDD complex (Baker and Reddy, 1998; Kidd, 1998; Nagata, 1997; Schmitt et al., 1999; Wallach et al., 1999) . Our observations may imply that the ability of PyLT-Ag to prevent caspase-8 activation is diminished in the TNF-R1 DISC or that TNF-R1 uses apoptotic pathways bypassing the DISC (Wallach et al., 1999) .
Following caspase-8 activation in TM4 cells, caspase-3 was activated and DNA fragmentation occurred rapidly (6 h later). In the TM4-PGKLT5 cells, the slow activation of caspase-8 delayed the subsequent activa- ± 4) , Anti-PyLT-Ag (lanes 5 ± 8), Anti-CASP8 (lanes 9 ± 12) were used as primary antibody to immunoprecipitate the complexes. Half of the reaction products were loaded on SDS ± PAGE and transferred on nitrocellulose. Immunodetection was realized with the same rat polyclonal antibodies against Py-TAgs (mm1a) as in (a). RIPA refers to extraction buer only Figure 6 Model of PyLT-Ag anti-apoptotic activity. Schematic representation of the potential subcellular localization where PyLT-Ag might exert its anti-apoptotic eect against FasR apoptotic stimulation
PyLT-Ag confers apoptotic protection to mouse cells F Rodier et al tion of caspase-3. However, even after caspase-3 activation, DNA degradation did not occur rapidly (30 h later). PyLT-Ag expression seems to prolong the interval between caspase-3 activation and the occurrence of DNA fragmentation. This result suggests that PyLT-Ag may also act downstream of caspase-3 activation, delaying the activation or activity of other caspases involved in the structural disintegration of the nuclei (Earnshaw, 1995; Lazebnik et al., 1995; Oberhammer et al., 1994) or alternatively, of apoptotic nucleases such as CAD or AIF that are involved in the DNA fragmentation processes (Sakahira et al., 1998; Susin et al., 1999) . Thus, PyLT-Ag might act at dierent levels of the apoptotic cascade depending on its cellular localization ( Figure 6 ). PyLT-Ag has previously been shown to indirectly activate the HSP70 promoter presumably by activating HSF1, a key regulator in stress responses (Kingston et al., 1986) . Indeed, several reports have indicated that stress proteins such as HSP70, can modulate apoptosis, including cell death receptor mediated apoptosis (Arrigo, 1998; Hohfeld, 1998; Jaattela et al., 1998; Samali and Orrenius, 1998; Schett et al., 1999; Vayssier and Polla, 1998) . Following TNF-R1 stimulation, HSP70 has been reported to act downstream of caspase-3 activation but before the appearance of DNA degradation (Jaattela et al., 1998) although recent results suggest that it can also act before the activation of caspase-3 (Beere et al., 2000; Li et al., 2000; Saleh et al., 2000) . This observation parallels the delayed appearance of DNA fragmentation after caspase-3 activation in our model. Moreover, PyLTAg not only appears to stimulate HSP70 expression indirectly, but it can directly bind and stimulate HSP70 enzymatic activity via its DNA J/CR1homology domain located within its amino-terminal sequences (Kelley and Georgopoulos, 1997). During continuous FasR(Ab) stimulation, PyLT-Ag can protect TM4-PGKLT5 cells from DNA degradation for up to 48 h. Initiation of DNA fragmentation after 48 h demonstrated that, under constant stimulation, the protection provided by PyLT-Ag was only transient. Whether these lengthy in vitro stimuli are relevant to the in vivo situation is not clear. The in vitro use of peptide derivatives that inhibit caspase activities fails to protect cells completely when they are maintained in apoptotic stimulation (McCarthy et al., 1997; Sane and Bertrand, 1999) . In addition, delayed DNA degradation observed in some studies was due to a switch from apoptosis to necrosis (Hirsch et al., 1997; Sane and Bertrand, 1999) . It is unclear, therefore, whether the delayed DNA degradation observed in TM4-PGKLT5 cells is related to a similar switch to necrosis.
Our results show that PyLT-Ag was able to protect cells from taxol-but not camptothecin-induced apoptosis. The apoptotic signaling pathways activated following taxol stimulation are still controversial, and while some reports suggest an important role for caspase-8 (Oyaizu et al., 1999) other reports suggest that caspase-3 is the more important target for activation (Perkins et al., 2000; Weigel et al., 2000) . In our experiments we can see a slight activation of caspase-8 in control and TM4-PGKLT3 cells which is mildly delayed in TM4-PGKLT5 cells and it is not clear whether caspase-8 is activated before or after caspase-3 activation. If caspase-8 activation is not essential for taxol induced apoptosis, it is possible that at least part of the protective activity of PyLT-Ag is directed towards the mitochondria, since chemotherapeutic agents, including taxol and camptothecin, activate apoptosis in a mitochondria-dependent manner that can be inhibited by Bcl-2 and Bcl-x L (Decaudin et al., 1998; Dole et al., 1995; Ibrado et al., 1996; Kharbanda et al., 1997; Schmitt et al., 1998; Simonian et al., 1997) . Expression level of antiapoptotic members of the Ced-9/Bcl-2 family often determine drug sensitivity or resistance in tumors (Reed, 1997) . The E1B 19-kDa protein, which also acts as a functional homolog of Bcl-2, contains a degenerate BH1 domain that mediates interaction of E1B 19-kDa with the pro-apoptotic proteins Bax, Bak and Bnip3 (Boyd et al., 1994; Chen et al., 1996; Han et al., 1996; Subramanian et al., 1995; Yasuda et al., 1998) . It has been postulated that SV40LT-Ag possesses a putative degenerate BH1 domain located in the amino-terminal portion of the protein (Conzen et al., 1997) . PyLT-Ag does possess this degenerate BH1 domain, however, as for SV40LT, the similarity with Bcl2 is relatively low and the sequence lacks the highly conserved GR tandem present in all family members including the evolutionarily distant Caenorhabdditis elegans. Whether this BH1-like domain of PyLT-Ag is functional despite the lack of the glycine moiety known to be highly important for Bcl-2 and E1B 19-kD functions (Chen et al., 1996; Yin et al., 1994) , is currently under investigation.
Viruses have evolved various biochemical functions that allow them not only to self-replicate, but also to induce cellular transformation. The ability of PyLT-Ag to protect cells from cell death receptor mediated apoptosis suggests that Py has developed strategies to confer immune privileges that allow the host cell to escape immune responses. Further characterization of the mechanisms by which viral proteins like PyLT-Ag modulate apoptosis will help in understanding how tumor cells evade the immune system.
Materials and methods
Cell culture
The NSO cell line was obtained from Dr B Massie (Institut de Recherche en Biotechnologie, Canada) and is also available at the American Type Culture Collection (ATCC). The TM4 and NIH3T3 cell lines were purchased from the ATCC. D4 cells, Sertoli cells derived from transgenic PyLT-Ag animals (Lebel, 1994) , were used as a positive control for PyLT-Ag expression in Figure 2a . Both TM4 and NSO cell lines were chosen because of their sensitivity to FasR(Ab) and because the TM4 Sertoli line was of the same origin as the D37-C1/PyLT-Ag expressing cells used previously (Lebel et al., 1996) . All cell lines were cultured in Dulbecco's modi®ed Eagle's media (DMEM) supplemented with 9% fetal bovine serum, 50 mg/ml gentamycin, 2.5 mg/ml fungizone and 100 U/ml streptomycin/penicillin. All cell culture products were from Gibco-BRL Life Technology. Cells were allowed to grow at 378C with the controlled addition of 5% CO 2 in the atmosphere.
Vectors and transfections
PCEP4LT was constructed by introducing the XhoI ± BamHI fragment of PyLT-Ag cDNA (derived from the A2 strain of Py) into the pCEP4 polylinker (Invitrogen) and was used to transfect TM4 and NSO cells. The PGKLT plasmid was constructed by introducing the BamHI ± BamHI fragment of PyLT-Ag cDNA into the PGK vector (a gift from Dr M McBurney, University of Ottawa, Canada) and was used to transfect TM4 and NIH3T3 cells. This vector is composed of the pUC19 backbone in which the mouse PGK5' and PGK3' regulatory regions have been inserted (McBurney et al., 1991) . The pSV2neo vector is a common G418 selection vector. All restriction and modi®cation enzymes were purchased from Pharmacia Canada. For transfection, cells were washed twice with PBS, resuspended in 400 ml DMEM including 20 mg of plasmid DNA and electroporated at 250 volts and 960 mFD. Cells were left at room temperature for 10 min before being seeded in fresh media. Selection with either 0.5 mg/ml hygromycinB or G418 was applied after 48 h.
Northern blots
RNA was extracted from 100 mm petri dishes con¯uent at 80% using Gibco TRIZOL TM . Ten mg of total RNA from cells were electrophoresed on 1% (w/v) agarose gel containing 2.2 M formaldehyde and 20 mM propane sulfonic acid, pH 6.8). RNA was transferred to a nitrocellulose membrane (Schleicher & Schuell) by capillary blotting with 106SSC (16SSC is 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0). The ®lters were baked at 808C for 2 h and hybridized overnight at 608C in 30% formamide, 0.35 M sodium phosphate, pH 7.2, 7% SDS, 1% bovine serum albumin and a random-primed [ 32 P]dCTP-labeled linearized plasmid containing the cloned fragment of interest. Filters were subsequently washed twice at 608C with 0.15 M sodium phosphate, containing 1% SDS and exposed to Kodak XAR-5 ®lm for 2 h to 5 days at 7708C with an intensifying screen. To reprobe speci®c Northern blots, ®lters were treated at 808C for 1 h in 0.03 M sodium phosphate, 0.1% SDS. To insure that the probe had been stripped, membranes were exposed at 7708C with an intensifying screen overnight. Either the complete PyLT-Ag cDNA 2300 bp, or a 300 bp fragment of the FasR cDNA, or a 600 bp fragment of human b-actin cDNA were used as probes. Probes were prepared using the Pharmacia random primed labeling kit and subsequently puri®ed by the Nucleotide Removal kit (Qiagen).
Western blots
Cells from a 80% con¯uent 100 mm petri dish were scraped, washed twice in ice cold PBS and proteins extracted by resuspending the cells directly in 100 ml of gel loading buer (50 mM Tris-HCl pH 6.8, 100 mM dithiothreitol, 2% SDS, 10% glycerol). The mixture was brie¯y sonicated (30 s) followed by centrifugation (10 min) in a tabletop centrifuge at 48C to remove particulates. Samples (50 mg) were loaded on a 10% Tris-glycine SDS-polyacrylamide gel and electrophoresed as described (Sambrook et al., 1989) . Proteins were electroblotted overnight onto a nitrocellulose membrane and probed for PyLT-Ag expression. We used a 1 : 300 dilution (in PBS, 5% milk) of a polyclonal antibody speci®c to Py-TAg's (BNR 2C1) which was produced by injection of PyB4a to form ascites in BN rats cells (Silver et al., 1978) . Commercially available antibodies were bought from SantaCruz and diluted appropriately (caspase-8 p20 (H-134) 1 : 250 and Hsp60 1 : 2000). Secondary biotinylated antibodies (BioCan Scienti®c) and tertiary streptavidin-horseradish peroxidase (Amersham) were used at dilutions of 1 : 500 and 1 : 1000, respectively. Blots were developed using enhanced chemiluminescence reagent (Boehringer-Mannheim).
Apoptosis induction
For FasR stimulation, a pre-treatment with 150 U/ml mouse g-IFN (Boehringer Mannheim) for 16 h followed by addition of 1 mg/ml FasR agonist antibodies (FasR(Ab), clone Jo2 Pharmingen) was used. Timeline and other experiments calculate time zero from the point of FasR(Ab) addition. For TNF-a (Boehringer-Mannheim), we used concentrations ranging from 1300 U/ml to 33 000 U/ml with or without g-IFN pre-treatment of 150 U/ml. Taxol and camptothecin were obtained from Sigma Chemicals Co. and treatments were performed as indicated.
DNA fragmentation assays
Cellular DNA was labeled for 48 h with 14 C-thymidine (20 nCi/ml) and then chased in isotope-free medium before treatment. DNA fragmentation was quantitated at various time points by DNA ®lter elution assays, in which cells are lysed directly onto a protein-adsorbent ®lter (Metricel membrane, 0.8-mm pore size, 25-mm diameter, Gelman Sciences Inc). The ®lter retains labeled high molecular weight DNA while allowing fragmented DNA in the cell lysate to pass through. First, cells were washed with PBS and the collected supernatant was labeled fraction 1. Cells lysis was done directly on the ®lter with LS-10 solution (0.2% sodium sarkosyl, 2 M NaCl, 0.04 M EDTA, pH 10.0) and lysates collected and labeled fraction 2. One subsequent ®lter wash was done with 0.02 M EDTA, pH 10.0, to remove residual DNA fragments and was labeled fraction 3. The ®lter, containing only high molecular weight DNA was labeled fraction 4. All fractions were counted individually by liquid scintillation spectrometry for 14 C-thymidine radioactivity. Total c.p.m. of fraction 1, 2 and 3 (fragmented DNA) divided by total c.p.m. of fraction 1, 2, 3 and 4 (total DNA)6100, gives a precise percentage of the amount of DNA fragmentation (Bertrand et al., 1995) .
Caspases activity monitoring
Caspases-8 and -3 activities were monitored using protein extracts obtained from treated and control cells. Proteins were extracted from one petri dish at 80% con¯uence. Cells were washed twice in ice-cold PBS directly on the dish and were then scraped and harvested at 3000 r.p.m. for 2 min in an eppendorf centrifuge at 48C. Surplus PBS was removed and cells were resuspended in 100 ml lysis buer (100 mM HEPES pH 7.4, 20% glycerol, 5 mM EDTA, 5 mM dithiothreitol and 0.1% NP-40) and left on ice with agitation for 30 min. The supernatants were collected and frozen at 7808C until used. For each determination, 100 mg of protein was diluted with lysis buer and¯uorescence was monitored continuously at 378C in a dual luminescence¯urometer (LS 50B Perkin-Elmer) for 1 min to establish a baseline. The speci®c derivative peptides z-DEVD-AFC (casp-3) and z-IETD-AMC (casp-8) obtained from Calbiochem were used as substrates at 200 mM ®nal concentration. Fluorescence was monitored for 10 min and enzyme activities were determined as initial velocities in¯uorescence units/mg/min. Data are expressed as activity relative to control untreated cells.
Immunoprecipitation
Immunoprecipitation reactions were performed following Santa Cruz Biotechnology protocols. Proteins were extracted in RIPA buer (16PBS, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% SDS) in the presence of COMPLETE TM , (Boehringer Manheim) protease inhibitor cocktail. Cells from three 100 mm tissue cultures dishes (70% con¯uence) were rinsed in PBS, scraped and resuspended in 200 ml extraction buer and rocked for 2 h at 48C. The mixture was brie¯y sonicated (30 s) followed by centrifugation (10 min) in a tabletop centrifuge at 48C to remove particulates. Supernatants were pre-cleared with goat control IgGs. Samples were divided in three and incubated with primary antibodies (SantaCruz, caspase-8 p20 (H-134), FADD (M-19) and Hsp60 (N-20) ) at a concentration of 10 mg/ml overnight.
Pellets of protein A/G PLUS-Agarose/primary antibodies/ complex were washed four times with RIPA buer before being analysed as described above (Western blot analysis).
